<DOC>
	<DOCNO>NCT02726451</DOCNO>
	<brief_summary>The primary objective study determine efficacy Sensi Peel® , Rejuvenating Serum , C &amp; E Strength Max skin care product subject undergo full facial rejuvenation , botulinum neurotoxin A and/or hyaluronic acid filler , improve appearance skin , patient satisfaction aesthetic appearance , project first impression . The secondary objective study examine patient satisfaction continuous use Sensi Peel® , Rejuvenating Serum , C &amp; E Strength Max product .</brief_summary>
	<brief_title>A Study Examine Effects Cosmeceutical Therapy Subjects Undergoing Full Facial Rejuvenation</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<criteria>Subject female age 21 60 ; Subject require full facial rejuvenation HA soft tissue filler and/or botulinum neurotoxin , per judgment PI designee ; Subject willing able provide write informed consent prior performance study related procedure ; Subject willing able comply protocol requirement ; Subject willing able provide write photo consent adhere photography video procedure removal jewelry makeup . Subjects receive facial filler 12month neurotoxin treatment 4month period prior enrollment ; Previous treatment resurface facial aesthetic procedure ( e.g . deep chemical peel laser treatment ) within 12month period prior enrollment ; Previous treatment photo rejuvenation therapy within 6month period prior enrollment ; Subjects plan undergo facial cosmetic surgery aesthetic procedure ( e.g . neurotoxin , dermal filler , laser treatment , chemical peel ) , specify protocol , course study ; A know allergy sensitivity component study ingredient ; Use systemic steroid anticoagulation medication ; Subjects history bleed disorder ; Subjects severe allergy manifest history anaphylaxis presence multiple severe allergy ; Subjects hypersensitivity botulinum neurotoxin ; Subject allergies gram positive bacterial protein ; Sensitivity sulfides ; Subjects allergy cow 's milk protein ; Subjects previous history sensitivity amide type local anesthetic ; Subject surgical alteration facial anatomy mark facial asymmetry ; Inflammation infection injection site ( ) ; Subjects history eyelid eyebrow ptosis ; Excessive dermatochalasis , deep dermal scarring , thick sebaceous skin ; Subjects neuromuscular disorder ; Use anticholinergic , aminoglycosides agent interfere neuromuscular transmission ( e.g. , curarelike agent ) , muscle relaxant ; Subjects immunodeficiencies HIV , lupus , scleroderma , systemic infection ; Pregnant , nursing , sexually active female subject childbearing potential willing use acceptable form contraception ( e.g. , barrier method use spermicidal agent , hormonal method , IUD , surgical sterilization , abstinence ) ; Current history chronic drug alcohol abuse ; Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study product ; Subjects , investigator 's opinion , history poor cooperation , noncompliance medical treatment , unreliability ; Enrollment active study involve use investigational device drug .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>